Medical - Devices
Compare Stocks
5 / 10Stock Comparison
POAS vs DBVT vs ALKS vs CODA vs PRGO
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Biotechnology
Aerospace & Defense
Drug Manufacturers - Specialty & Generic
POAS vs DBVT vs ALKS vs CODA vs PRGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Devices | Biotechnology | Biotechnology | Aerospace & Defense | Drug Manufacturers - Specialty & Generic |
| Market Cap | $32M | $1713.21T | $6.38B | $133M | $1.54B |
| Revenue (TTM) | $2M | $0.00 | $1.56B | $28M | $4.18B |
| Net Income (TTM) | $-2M | $-168M | $153M | $4M | $-1.82B |
| Gross Margin | 47.7% | — | 65.4% | 66.3% | 34.2% |
| Operating Margin | -132.9% | — | 12.3% | 17.4% | -4.1% |
| Forward P/E | — | — | 26.8x | 22.3x | 5.3x |
| Total Debt | $793K | $22M | $70M | $395K | $3.97B |
| Cash & Equiv. | $2M | $194M | $1.12B | $29M | $532M |
POAS vs DBVT vs ALKS vs CODA vs PRGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| DBV Technologies S.… (DBVT) | 100 | 41.2 | -58.8% |
| Alkermes plc (ALKS) | 100 | 234.0 | +134.0% |
| Coda Octopus Group,… (CODA) | 100 | 211.3 | +111.3% |
| Perrigo Company plc (PRGO) | 100 | 20.3 | -79.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: POAS vs DBVT vs ALKS vs CODA vs PRGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
POAS has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 189.3%, EPS growth 100.0%
- 189.3% revenue growth vs DBVT's -100.0%
- Beta 0.14 vs DBVT's 1.26
DBVT is the clearest fit if your priority is momentum.
- +97.4% vs PRGO's -54.5%
Among these 5 stocks, ALKS doesn't own a clear edge in any measured category.
CODA is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 7.4% 10Y total return vs ALKS's 3.5%
- Lower volatility, beta 0.99, Low D/E 0.7%, current ratio 8.86x
- Beta 0.99, current ratio 8.86x
- 14.8% margin vs POAS's -125.3%
PRGO ranks third and is worth considering specifically for income & stability.
- Dividend streak 10 yrs, beta 1.21, yield 10.3%
- Lower P/E (5.3x vs 22.3x)
- 10.3% yield; 10-year raise streak; the other 4 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 189.3% revenue growth vs DBVT's -100.0% | |
| Value | Lower P/E (5.3x vs 22.3x) | |
| Quality / Margins | 14.8% margin vs POAS's -125.3% | |
| Stability / Safety | Beta 0.14 vs DBVT's 1.26 | |
| Dividends | 10.3% yield; 10-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +97.4% vs PRGO's -54.5% | |
| Efficiency (ROA) | 6.6% ROA vs DBVT's -89.0% |
POAS vs DBVT vs ALKS vs CODA vs PRGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
POAS vs DBVT vs ALKS vs CODA vs PRGO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CODA leads in 2 of 6 categories
PRGO leads 2 • ALKS leads 1 • POAS leads 0 • DBVT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CODA leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. CODA is the more profitable business, keeping 14.8% of every revenue dollar as net income compared to POAS's -125.3%. On growth, CODA holds the edge at +28.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2M | $0 | $1.6B | $28M | $4.2B |
| EBITDAEarnings before interest/tax | — | -$112M | $212M | $6M | $58M |
| Net IncomeAfter-tax profit | — | -$168M | $153M | $4M | -$1.8B |
| Free Cash FlowCash after capex | — | -$151M | $392M | $7M | $108M |
| Gross MarginGross profit ÷ Revenue | +47.7% | — | +65.4% | +66.3% | +34.2% |
| Operating MarginEBIT ÷ Revenue | -132.9% | — | +12.3% | +17.4% | -4.1% |
| Net MarginNet income ÷ Revenue | -125.3% | — | +9.8% | +14.8% | -43.5% |
| FCF MarginFCF ÷ Revenue | -91.9% | — | +25.1% | +24.6% | +2.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | +28.2% | +28.8% | -7.2% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +91.5% | -4.1% | +3.0% | -56.4% |
Valuation Metrics
PRGO leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 26.8x trailing earnings, ALKS trades at a 16% valuation discount to CODA's 32.0x P/E. On an enterprise value basis, PRGO's 7.3x EV/EBITDA is more attractive than ALKS's 19.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $32M | $1713.21T | $6.4B | $133M | $1.5B |
| Enterprise ValueMkt cap + debt − cash | $31M | $1713.21T | $5.3B | $105M | $5.0B |
| Trailing P/EPrice ÷ TTM EPS | — | -0.76x | 26.78x | 31.97x | -1.08x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 22.32x | 5.25x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 7.46x | — |
| EV / EBITDAEnterprise value multiple | — | — | 18.97x | 17.72x | 7.31x |
| Price / SalesMarket cap ÷ Revenue | 21.75x | — | 4.32x | 5.02x | 0.36x |
| Price / BookPrice ÷ Book value/share | — | 0.66x | 3.55x | 2.29x | 0.52x |
| Price / FCFMarket cap ÷ FCF | — | — | 13.29x | 22.07x | 10.60x |
Profitability & Efficiency
ALKS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-130 for DBVT. CODA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs PRGO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -80.8% | -130.2% | +8.8% | +7.2% | -50.7% |
| ROA (TTM)Return on assets | -71.9% | -89.0% | +5.4% | +6.6% | -19.8% |
| ROICReturn on invested capital | — | — | +18.9% | +11.2% | +3.7% |
| ROCEReturn on capital employed | -6.5% | -145.7% | +14.2% | +8.1% | +4.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 7 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.27x | 0.13x | 0.04x | 0.01x | 1.35x |
| Net DebtTotal debt minus cash | -$2M | -$172M | -$1.0B | -$28M | $3.4B |
| Cash & Equiv.Liquid assets | $2M | $194M | $1.1B | $29M | $532M |
| Total DebtShort + long-term debt | $792,580 | $22M | $70M | $394,932 | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | -57.49x | -189.82x | 32.30x | — | -7.20x |
Total Returns (Dividends Reinvested)
CODA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALKS five years ago would be worth $17,063 today (with dividends reinvested), compared to $3,311 for DBVT. Over the past 12 months, DBVT leads with a +97.4% total return vs PRGO's -54.5%. The 3-year compound annual growth rate (CAGR) favors CODA at 11.0% vs PRGO's -25.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -25.6% | +5.0% | +35.5% | +24.4% | -17.9% |
| 1-Year ReturnPast 12 months | -39.0% | +97.4% | +22.4% | +75.8% | -54.5% |
| 3-Year ReturnCumulative with dividends | -39.0% | +1.0% | +22.9% | +36.6% | -58.8% |
| 5-Year ReturnCumulative with dividends | -39.0% | -66.9% | +70.6% | +52.6% | -63.9% |
| 10-Year ReturnCumulative with dividends | -39.0% | -86.7% | +3.5% | +745.0% | -77.2% |
| CAGR (3Y)Annualised 3-year return | -15.2% | +0.3% | +7.1% | +11.0% | -25.6% |
Risk & Volatility
Evenly matched — POAS and ALKS each lead in 1 of 2 comparable metrics.
Risk & Volatility
POAS is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 99.6% from its 52-week high vs POAS's 31.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.14x | 1.26x | 1.00x | 0.99x | 1.21x |
| 52-Week HighHighest price in past year | $7.39 | $26.18 | $38.45 | $17.28 | $28.44 |
| 52-Week LowLowest price in past year | $0.53 | $7.53 | $25.17 | $5.98 | $9.23 |
| % of 52W HighCurrent price vs 52-week peak | +31.8% | +76.4% | +99.6% | +68.5% | +39.1% |
| RSI (14)Momentum oscillator 0–100 | 61.9 | 50.3 | 60.0 | 50.9 | 45.1 |
| Avg Volume (50D)Average daily shares traded | 400K | 243K | 2.2M | 253K | 3.1M |
Analyst Outlook
PRGO leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: DBVT as "Buy", ALKS as "Buy", CODA as "Buy", PRGO as "Hold". Consensus price targets imply 225.5% upside for PRGO (target: $36) vs 18.3% for CODA (target: $14). PRGO is the only dividend payer here at 10.34% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $46.33 | $46.00 | $14.00 | $36.20 |
| # AnalystsCovering analysts | — | 15 | 28 | 1 | 36 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +10.3% |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | 0 | 10 |
| Dividend / ShareAnnual DPS | — | — | — | — | $1.15 |
| Buyback YieldShare repurchases ÷ mkt cap | +7.0% | 0.0% | +0.5% | 0.0% | 0.0% |
CODA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). PRGO leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
POAS vs DBVT vs ALKS vs CODA vs PRGO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is POAS or DBVT or ALKS or CODA or PRGO a better buy right now?
For growth investors, Phaos Technology Holdings (Cayman) Limited (POAS) is the stronger pick with 189.
3% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Alkermes plc (ALKS) offers the better valuation at 26. 8x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — POAS or DBVT or ALKS or CODA or PRGO?
On trailing P/E, Alkermes plc (ALKS) is the cheapest at 26.
8x versus Coda Octopus Group, Inc. at 32. 0x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — POAS or DBVT or ALKS or CODA or PRGO?
Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +70.
6%, compared to -66. 9% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: CODA returned +745. 0% versus DBVT's -86. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — POAS or DBVT or ALKS or CODA or PRGO?
By beta (market sensitivity over 5 years), Phaos Technology Holdings (Cayman) Limited (POAS) is the lower-risk stock at 0.
14β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 792% more volatile than POAS relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.
05Which is growing faster — POAS or DBVT or ALKS or CODA or PRGO?
By revenue growth (latest reported year), Phaos Technology Holdings (Cayman) Limited (POAS) is pulling ahead at 189.
3% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Phaos Technology Holdings (Cayman) Limited grew EPS 100. 0% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — POAS or DBVT or ALKS or CODA or PRGO?
Alkermes plc (ALKS) is the more profitable company, earning 16.
4% net margin versus -125. 3% for Phaos Technology Holdings (Cayman) Limited — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -132. 9% for POAS. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is POAS or DBVT or ALKS or CODA or PRGO more undervalued right now?
On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.
3x forward P/E versus 22. 3x for Coda Octopus Group, Inc. — 17. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 225. 5% to $36. 20.
08Which pays a better dividend — POAS or DBVT or ALKS or CODA or PRGO?
In this comparison, PRGO (10.
3% yield) pays a dividend. POAS, DBVT, ALKS, CODA do not pay a meaningful dividend and should not be held primarily for income.
09Is POAS or DBVT or ALKS or CODA or PRGO better for a retirement portfolio?
For long-horizon retirement investors, Phaos Technology Holdings (Cayman) Limited (POAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
14)). Both have compounded well over 10 years (POAS: -39. 0%, DBVT: -86. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between POAS and DBVT and ALKS and CODA and PRGO?
These companies operate in different sectors (POAS (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and CODA (Industrials) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: POAS is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; CODA is a small-cap high-growth stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while POAS, DBVT, ALKS, CODA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.